Xtant Medical Holdings, Inc. (XTNT)

NYSEAMERICAN: XTNT · Real-Time Price · USD

0.3315

+0.0265 (8.69%)

At close: Aug 17, 2026, 4:00 PM EDT

0.3300

-0.0015 (-0.45%)

Pre-market: Aug 18, 2026, 4:43 AM EDT

Xtant Medical Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	109.53	133.93	117.27	91.3	57.97	55.15
Other Revenue	-	-	-	-	-	0.12
Revenue	109.53	133.93	117.27	91.3	57.97	55.26
Revenue Growth	-14.27%	14.21%	28.44%	57.50%	4.90%	3.61%
Cost of Revenue	44.48	49.65	49.05	35.84	25.83	22.77
Gross Profit	65.05	84.27	68.22	55.47	32.14	32.49
Selling, General & Admin	68.32	74.89	77.91	64.29	37.98	34.87
Research & Development	2.22	2.1	2.39	1.34	0.92	0.87
Operating Expenses	70.54	76.99	80.29	65.63	38.89	35.74
Operating Income	-5.5	7.28	-12.07	-10.16	-6.76	-3.25
Interest Expense	-2.76	-3.67	-4.16	-2.94	-1.69	-1
Interest & Investment Income	0.31	0.09	-	0.15	0.03	-
Currency Exchange Gain (Loss)	-0.24	-0.06	0.01	0.27	-	-
Other Non Operating Income (Expenses)	-4.34	0.07	-0.03	-0.05	-	-
EBT Excluding Unusual Items	-12.52	3.72	-16.26	-12.73	-8.42	-4.25
Gain (Loss) on Sale of Assets	3.28	3.28	-	-	-	-
Legal Settlements	-	-	-	-	-	-0.6
Other Unusual Items	-	-	-	11.69	-	-
Pretax Income	-9.24	7	-16.26	-1.04	-8.42	-4.85
Income Tax Expense	1.9	2.03	0.19	-1.7	0.07	-
Net Income	-11.14	4.97	-16.45	0.66	-8.49	-4.85
Net Income to Common	-11.14	4.97	-16.45	0.66	-8.49	-4.85
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	140	140	134	119	94	85
Shares Outstanding (Diluted)	140	150	134	127	94	85
Shares Change	1.38%	12.25%	5.42%	34.76%	10.10%	199.85%
EPS (Basic)	-0.08	0.04	-0.12	0.01	-0.09	-0.06
EPS (Diluted)	-0.08	0.03	-0.12	0.01	-0.09	-0.06
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-0.7	10.16	-16.01	-10.97	-7.11	-1.68
Free Cash Flow Per Share	-0.01	0.07	-0.12	-0.09	-0.08	-0.02
Gross Margin	59.39%	62.92%	58.17%	60.75%	55.44%	58.79%
Operating Margin	-5.02%	5.44%	-10.30%	-11.13%	-11.65%	-5.89%
Profit Margin	-10.17%	3.71%	-14.03%	0.72%	-14.64%	-8.77%
Free Cash Flow Margin	-0.64%	7.59%	-13.65%	-12.02%	-12.26%	-3.03%
EBITDA	-1.47	12.51	-7.85	-6.98	-5.46	-1.92
EBITDA Margin	-1.34%	9.34%	-6.69%	-7.65%	-9.42%	-3.48%
D&A For EBITDA	4.02	5.22	4.22	3.17	1.29	1.33
EBIT	-5.5	7.28	-12.07	-10.16	-6.76	-3.25
EBIT Margin	-5.02%	5.44%	-10.30%	-11.13%	-11.65%	-5.89%
Effective Tax Rate	-	28.97%	-	-	-	-
Revenue as Reported	109.53	133.93	117.27	91.3	-	55.26

SEC Filings: 10-K · 10-Q